• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Vertex Pharmaceuticals Incorporated (VRTX)

    -NMS
    118.90 Up 1.16(0.99%) Dec 19, 4:00PM EST
    |After Hours : 119.36 Up 0.46 (0.39%) Dec 19, 7:08PM EST
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Net Income (445,028) (107,032) 29,574  
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation48,365  38,191  53,450  
    Adjustments To Net Income592,666  292,602  241,270  
    Changes In Accounts Receivables53,363  39,912  (170,606)
    Changes In Liabilities(53,495)1,815  79,472  
    Changes In Inventories7,142  (29,925)(111,388)
    Changes In Other Operating Activities(12,061)(23,619)10,358  
    Total Cash Flow From Operating Activities (51,570) 267,841   143,735  
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(51,393)(71,140)(34,595)
    Investments(64,123)(337,902)294,495  
    Other Cash flows from Investing Activities61,386  (16,775)(47,488)
    Total Cash Flows From Investing Activities (54,130) (425,817) 212,412  
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock265,878  191,721  124,862  
    Net Borrowings(83,742)(21,488)(155,000)
    Other Cash Flows from Financing Activities -   -   -  
    Total Cash Flows From Financing Activities 180,884   172,204   (124,238)
    Effect Of Exchange Rate Changes4,708  (141)214  
    Change In Cash and Cash Equivalents 79,892   14,087   232,123  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.